Bio-Rad Laboratories, Inc. Class B (BIO.B) Stock Statistics & Valuation Metrics

Bio-Rad Laboratories, Inc. Class B has a market cap or net worth of $10.00B. The enterprise value is $7.96B.

Market Cap

$10.00B

Enterprise Value

$7.96B

Bio-Rad Laboratories, Inc. Class B has 5,061,038 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

5,061,038

Owned by Insiders

0.06%

Owned by Institutions

0.02%

Bio-Rad Laboratories, Inc. Class B’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 2.04%.

Return on Equity (ROE)

0.10

Return on Assets (ROA)

0.07

Return on Invested Capital (ROIC)

2.04%

Return on Capital Employed (ROCE)

0.03

Revenue Per Employee

346.74K

Profits Per Employee

102.00K

Employee Count

7,450

Asset Turnover

0.24

Inventory Turnover

1.67

The current PE Ratio of Bio-Rad Laboratories, Inc. Class B is 44.68. Bio-Rad Laboratories, Inc. Class B’s PEG ratio is -0.15.

PE Ratio

44.68

PS Ratio

3.84

PB Ratio

1.39

Price to FCF

28.18

Price to Operating Cash Flow

20.21

PEG Ratio

-0.15

In the last 12 months, Bio-Rad Laboratories, Inc. Class B had revenue of 2.58B and earned 759.90M in profits. Earnings per share was 27.87.

Revenue

2.58B

Gross Profit

1.34B

Operating Income

270.50M

Pretax Income

995.50M

Net Income

759.90M

EBITDA

1.21B

Earnings Per Share (EPS)

27.87

In the last 12 months, operating cash flow was 492.60M and capital expenditures -139.50M, giving a free cash flow of 353.10M billion.

Operating Cash Flow

492.60M

Free Cash Flow

353.10M

Free Cash Flow per Share

13.20

Bio-Rad Laboratories, Inc. Class B pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

3.55%

Earnings Yield

2.23%

Beta

1.01

52-Week Price Change

26.09%

50-Day Moving Average

382.98

200-Day Moving Average

318.61

Relative Strength Index (RSI)

53.50

Average Volume (3m)

157

Bio-Rad Laboratories, Inc. Class B upcoming earnings date is Nov 04, 2026, After Close (Not Confirmed).

Last Earnings Date

Aug 04, 2026

Next Earnings Date

Nov 04, 2026

Ex-Dividend Date

―

Bio-Rad Laboratories, Inc. Class B as a current ratio of 5.62, with Debt / Equity ratio of 20.54%

Current Ratio

5.62

Quick Ratio

4.19

Debt to Market Cap

0.17

Net Debt to EBITDA

0.83

Interest Coverage Ratio

5.52

In the past 12 months, Bio-Rad Laboratories, Inc. Class B has paid 235.60M in taxes.

Income Tax

235.60M

Effective Tax Rate

0.24

Bio-Rad Laboratories, Inc. Class B EV to EBITDA ratio is 20.67, with an EV/FCF ratio of 30.13.

EV to Sales

4.11

EV to EBITDA

20.67

EV to Free Cash Flow

30.13

EV to Operating Cash Flow

21.60

Bio-Rad Laboratories, Inc. Class B has $1.62B in cash and marketable securities with $1.20B in debt, giving a net cash position of $414.80M billion.

Cash & Marketable Securities

$1.62B

Total Debt

$1.20B

Net Cash

$414.80M

Net Cash Per Share

$81.96

Tangible Book Value Per Share

$240.77

Gross margin is 51.90%, with operating margin of 9.08%, and net profit margin of 8.59%.

Gross Margin

51.90%

Operating Margin

9.08%

Pretax Margin

13.53%

Net Profit Margin

8.59%

EBITDA Margin

19.88%

EBIT Margin

14.95%

The average price target for Bio-Rad Laboratories, Inc. Class B is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

1.37%

EPS Growth Forecast

-29.25%

Smart Score

6

AI Score

60